| 摘要 |
The present disclosure provides carbon nanotube substrates, and methods of using those substrates, for the treatment and/or amelioration of neurological conditions associated with elevated levels of neural chloride. One aspect of the present disclosure provides a substrate comprising, consisting of or consisting essentially of high-conductivity few-walled CNTs dispersed thereon, wherein the CNTs comprise an intrinsic electrical conductivity of at least 2,500 S/cm. In certain embodiments, the CNTs comprise an intrinsic electrical conductivity in a range of about 1,000 S/cm to about 3,000 S/cm. In an alternative embodiment, the CNTs compromise an intrinsic electrical conductivity in a range of about 1,500 S/cm to about 2,500 S/cm. |
